[Federal Register Volume 65, Number 22 (Wednesday, February 2, 2000)]
[Notices]
[Page 4999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-2153]



[[Page 4999]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 19, 1999, Norac 
Company, Inc., 405 S. Motor Avenue, Azusa, California 91702, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk of manufacturer of tetrahydrocannabinols (7370), 
a basic class of controlled substance listed in Schedule I.
    The firm plans to manufacture medication for the treatment of AIDS 
wasting syndrome and as an antiemetic.
    And other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 3, 2000.

    Dated: December 22, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-2153 Filed 2-1-00 8:45 am]
BILLING CODE 4410-09-M